Innovation

Solutions: A Symbiotic Relationship

UTHealth researchers are working on a new treatment for oral thrush


By Christine Hall | July 05, 2017

This is a story about a fungus—the cause of some serious infections in hospitalized patients—and a group of microbiologists with McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) who want to develop a new antifungal drug.

Two of the most problematic causes of infections are Enterococcus faecalis, a bacterium, and Candida albicans, a fungus, often found together in the gastrointestinal region. These microbes can also co-habitate in the mouth; some studies have found evidence of both in materials extracted from infected root canals.

The presence of these two microbes in the same parts of the body led Michael Lorenz, Ph.D., a professor of microbiology and molecular genetics at UTHealth, and his colleague, Danielle Garsin, Ph.D., associate professor of microbiology and molecular genetics, to wonder how the organisms might affect one another.

When the researchers put the two organisms together, they noticed something interesting.

“We thought the two together would make infections worse,” Lorenz said. “What ended up happening was unexpected and fascinating: Enterococcus was actually returning Candida to a benign state.”

Doctoral student Carrie Graham deduced that a protein made by the bacterium, EntV, was blocking the fungus’ biofilm development. The interaction was inhibiting the Candida’s virulence, but not harming it. In fact, it was a completely new type of activity for this protein.

Using this newfound knowledge, the researchers wondered if this EntV protein would be effective against a Candida infection, in this case oral thrush—a yeast infection of the mouth and throat that affects millions, particularly babies, seniors and people with weakened immune systems.

In a mouse model, the researchers found that the animals treated with the antimicrobial protein had fewer symptoms—including a reduction in the creamy, white lesions associated with oral thrush—than those who were not treated with the antimicrobial protein. Their results were reported in the April issue of Proceedings of the National Academy of Sciences of the United States of America.

“These findings demonstrate that EntV has potential as an antifungal agent that targets virulence rather than viability,” the researchers wrote in their study.

The next steps are for Garsin’s lab to determine how EntV is produced in Enterococcus, and Lorenz’s lab to determine how EntV makes Candida less infectious. The researchers are also trying to determine how the protein could be used in a clinical setting.

“It’s probably many years away,” Lorenz said, “in part because the protein needs to be modified to make it a suitable therapeutic.”

More testing will determine whether EntV is effective against strains of Candida resistant to traditional antifungals and whether it can be used with them to improve outcomes.

“The long-term goal is to develop a new antifungal drug that takes a different approach to treating oral thrush,” Garsin said.

 

Tags | Innovation



Social Posts

profile_image

BCMHouston

@bcmhouston

RT @BCMEthics: Alternative science: The importance of informed policymaking https://t.co/O3lLsZAsr3 via @bcmhouston

8 mins ago
profile_image

Rice University

@RiceUniversity

Here?s a tip: Indented cement shows unique properties. https://t.co/GuxKPV2NgV https://t.co/XBSiKhJ5IG

12 mins ago
profile_image

BCMHouston

@bcmhouston

Congratulations to Drs. Jonathan Davies, James Orengo and Geoffrey Preidis, recipients of the 2017 Chao Physician-S? https://t.co/8OZYgv4laf

12 mins ago
profile_image

BCMHouston

@bcmhouston

@BCMEthics' Cody Brannan says peer-reviewed data should be considered for science-based policymaking. https://t.co/nkLOkMfQ7h

12 mins ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Baylor College of Medicine Center for Medical Ethics and Health Policy's Cody Brannan says peer-reviewed data and scientific consensus should be considered fo...

12 mins ago
profile_image

MD Anderson

@MDAndersonNews

@RandyPro Congratulations, Randy! Best wishes to you.

21 mins ago
profile_image

CHI St Luke's Health

@CHI_StLukes

RT @CHI_Updates: Even hours after a near-drowning incident, mild symptoms can cause serious complications - learn more with this info from?

32 mins ago
profile_image

MD Anderson

@MDAndersonNews

Tips for enjoying a healthy #barbecue: https://t.co/p4NKLod53I @FocusedonHealth #endcancer https://t.co/iaP5EstrZP

39 mins ago
profile_image

UTHealth

@UTHealth

RT @UTSDhouston: I scream! You scream! We all scream for ice cream! Dean Valenza's 9th Annual Scream Out ice? https://t.co/kzog82SPID

57 mins ago
profile_image

Texas Children's

@TexasChildrens

"This doctor, who I didn't know at the time, was going to change our lives." Read full story: https://t.co/3Kn1q4rap6 #texaschildrens

57 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Magic Valley groups ride to honor Vietnam Veterans https://t.co/Bc1PCvQYfH via @emilydukeKMVT

58 mins ago
profile_image

Rice University

@RiceUniversity

Communities of cells communicate to coordinate their actions, but how do they coordinate with other communities?? https://t.co/TynLuAsTS6

1 hour ago
profile_image

UTHealth

@UTHealth

#Trampolines are responsible for thousands of annual ER visits. Dr. Sasha Adams shared safety tips w/ @Fox26Houston: https://t.co/4sbo09Lc1j

1 hour ago
profile_image

UTHealth

@UTHealth

After 3-year-old Ishaan fell into a pool and nearly drowned, he was fortunate to be in the care of Dr. Soham Roy: https://t.co/rCkS06zkUs

1 hour ago
profile_image

MD Anderson Cancer Center

MDAnderson

“I wasn’t going to give up. If there’s any chance, I’m going to take it,” Maria Newhouse recalls telling herself when she was diagnosed with breast cancer. Lea...

1 hour ago